Peter Pinto

Peter Pinto

UNVERIFIED PROFILE

Are you Peter Pinto?   Register this Author

Register author
Peter Pinto

Peter Pinto

Publications by authors named "Peter Pinto"

Are you Peter Pinto?   Register this Author

100Publications

3322Reads

33Profile Views

Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy.

Int Urol Nephrol 2019 Aug 16;51(8):1349-1355. Epub 2019 May 16.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 3-1621 NW, Bethesda, MD, 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-019-02168-4DOI Listing
August 2019

Apical periurethral transition zone lesions: MRI and histology findings.

Abdom Radiol (NY) 2019 Aug 29. Epub 2019 Aug 29.

Molecular Imaging Program, NCI, NIH, 10 Center Drive, Room B3B85, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-019-02194-xDOI Listing
August 2019

Super active surveillance for low-risk prostate cancer | Opinion: No.

Int Braz J Urol 2019 Mar-Apr;45(2):215-219

Department of Urology, University of Southern California, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/S1677-5538.IBJU.2019.02.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541137PMC
July 2019

Contemporary treatments in prostate cancer focal therapy.

Curr Opin Oncol 2019 May;31(3):200-206

Urologic Oncology Branch (UOB), National Cancer Institute (NCI).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465079PMC
May 2019

The role of multiparametric MRI in biopsy-naive prostate cancer.

Nat Rev Urol 2019 May;16(5):276-277

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41585-019-0173-7DOI Listing
May 2019

Fully automated prostate whole gland and central gland segmentation on MRI using holistically nested networks with short connections.

J Med Imaging (Bellingham) 2019 Apr 5;6(2):024007. Epub 2019 Jun 5.

National Institutes of Health Clinical Center, Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Radiology and Imaging Sciences, Bethesda, Maryland, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1117/1.JMI.6.2.024007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551111PMC
April 2019

Learning deep similarity metric for 3D MR-TRUS image registration.

Int J Comput Assist Radiol Surg 2019 Mar 31;14(3):417-425. Epub 2018 Oct 31.

Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11548-018-1875-7
Publisher Site
http://dx.doi.org/10.1007/s11548-018-1875-7DOI Listing
March 2019

Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.

Urol Oncol 2019 03 3;37(3):182.e1-182.e8. Epub 2018 Dec 3.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439183046
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2018.11.018DOI Listing
March 2019

A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Radiology 2019 Mar 22;290(3):709-719. Epub 2019 Jan 22.

From the Department of Urology and Pediatric Urology, University Medical Center, Mainz, Germany (S.M.); Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (S.M., J.B., S.G., G.H., K.R., P.A.P.); Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892-1088 (S.M., C.S., M.C., P.L.C., B.T.); Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Md (J.H.S.); Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, NCI Campus at Frederick, Frederick, Md (S.H.); Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Md (M.J.M.); and Center for Interventional Oncology, National Cancer Institute and Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Md (B.J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018181278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394788PMC
March 2019

Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.

AJR Am J Roentgenol 2019 Mar 27:1-8. Epub 2019 Mar 27.

14 National Institutes of Health Clinical Center, Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Radiology and Imaging Sciences, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.18.20536DOI Listing
March 2019

Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?

World J Urol 2019 Feb 21;37(2):235-241. Epub 2018 May 21.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Dr. Building 10, Room 1-5950, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2337-0DOI Listing
February 2019

Template for MR Visualization and Needle Targeting.

Ann Biomed Eng 2019 Feb 28;47(2):524-536. Epub 2018 Nov 28.

School of Electrical and Computer Engineering, University of Georgia, Athens, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10439-018-02167-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570497PMC
February 2019

A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).

Acad Radiol 2019 01 25;26(1):5-14. Epub 2018 Apr 25.

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B85, Bethesda, MD 20814. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2018.03.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202287PMC
January 2019

Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

Abdom Radiol (NY) 2018 12;43(12):3436-3444

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B85, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-018-1631-zDOI Listing
December 2018

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.

J Urol 2018 11 29;200(5):1041-1047. Epub 2018 May 29.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.05.094DOI Listing
November 2018

MRI to guide biopsies or avoid biopsies?

Curr Opin Urol 2018 11;28(6):522-528

Departments of Urology and Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000555DOI Listing
November 2018

Sentinel lymph node imaging in urologic oncology.

Transl Androl Urol 2018 Oct;7(5):887-902

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://tau.amegroups.com/article/view/21133/21414
Publisher Site
http://dx.doi.org/10.21037/tau.2018.08.23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212622PMC
October 2018

Morphological changes induced by intraprostatic PSA-based vaccine in prostate cancer biopsies (phase I clinical trial).

Hum Pathol 2018 08 30;78:72-78. Epub 2018 Apr 30.

Laboratory of Tumor Immunology and Biology, CCR, NCI, NIH, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.04.013DOI Listing
August 2018

Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer.

Radiology 2018 08 22;288(2):485-491. Epub 2018 May 22.

From the Center for Interventional Oncology (J.N.T., H.A.N., P.S., B.J.W.), Molecular Imaging Program (F.V.M., P.L.C., B.T.), Laboratory of Pathology (M.J.M.), and Urologic Oncology Branch (P.A.P.), National Cancer Institute and Clinical Center, National Institutes of Health, 10 Center Dr, Building 10, MSC 1182, Room B3B85, Bethesda, MD 20892; Department of Urology, University of Michigan Health System, Ann Arbor, Mich (A.K.G.); and Department of Surgery, Division of Urology, University of Maryland Medical Center, Baltimore, Md (M.M.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018170425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071681PMC
August 2018

Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems.

AJR Am J Roentgenol 2018 Jul 7;211(1):W33-W41. Epub 2018 May 7.

1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, Rm B3B85, Bethesda, MD 20814.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.17.18702DOI Listing
July 2018

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

N Engl J Med 2018 May 18;378(19):1767-1777. Epub 2018 Mar 18.

From University College London (UCL) and UCL Hospitals NHS Foundation Trust (V.K., C.A., F.G., A.F., S.M., S.P., M.E., C.M.M.), London North West Healthcare NHS Trust (G.H.), Whittington Health NHS Trust (M.G.), Royal Free London NHS Foundation Trust (P.B.S.), and UCL Surgical and Interventional Trials Unit (N.R.W., C.B.-G.), London, Hampshire Hospitals NHS Foundation Trust, Basingstoke (R.G.H.), Princess Alexandra Hospital NHS Trust, Harlow (J.V.), and the Institute of Applied Health Research and the NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham (J.D., Y.T.) - all in the United Kingdom; Helsinki University and Helsinki University Hospital, Helsinki (A.S.R.), and Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu (M.H.V.) - all in Finland; Centro de Urología, Buenos Aires (M.B.); Sapienza University, Rome (V.P.), and IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan (A.B.) - all in Italy; Mayo Clinic, Rochester, MN (L.A.M.); Martini Klinik, Hamburg (L.B.), University Hospital Essen, Essen (B.A.H.), and University Hospital Heidelberg, Heidelberg (B.A.H.) - all in Germany; Erasmus University Medical Center, Rotterdam (M.J.R.), and Radboud University Medical Center, Nijmegen (W.V.) - both in the Netherlands; University of Chicago, Chicago (S.E.); Université de Lille and Centre Hospitalier Universitaire Lille, Lille (A.V.), Université de Bordeaux and Bordeaux Pellegrin University Hospital, Bordeaux (G.R.), and Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud (A.R.), and Hospices Civils de Lyon of the Hôpital Edouard Herriot (S.C.), Lyon - all in France; Jewish General Hospital, Montreal (F.B.), and Sunnybrook Health Sciences Centre, Toronto (L.K.) - both in Canada; Ghent University Hospital, Ghent, Belgium (G.M.V.); University Hospital Bern, Bern, Switzerland (S.B.); Weill Cornell Medicine, New York-Presbyterian Hospital (J.C.H., D.M.), and New York University Langone Medical Center (S.S.T.), New York; National Institutes of Health, Bethesda, MD (P.P.); and the University of Southern California Institute of Urology, Keck School of Medicine, Los Angeles (I.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1801993DOI Listing
May 2018

The disappearing PI-RADS 5 prostate lesion.

Can J Urol 2018 04;25(2):9281-9283

Department of Urology, George Washington University Hospital, Washington, DC, USA.

View Article

Download full-text PDF

Source
April 2018

Targeted biopsy: benefits and limitations.

Curr Opin Urol 2018 03;28(2):219-226

Urologic Oncology Branch.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000481DOI Listing
March 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.

Radiology 2018 01 20;286(1):186-195. Epub 2017 Oct 20.

From the Molecular Imaging Program (S.B., S.G., M.B., M.D.G., F.V.M., P.L.C., B.T.), Urologic Oncology Branch (A.K.G.), and Laboratory of Pathology (V.M., M.J.M.), National Cancer Institute, National Institutes of Health, 10 Center Dr, Room B3B85, Bethesda, MD 20892; Department of Radiology, George Washington University Hospital, Washington, DC (S.B., M.T., P.A.P.); and Center for Interventional Oncology, National Cancer Institute, and Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Md (B.J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017152877DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749595PMC
January 2018

Ruling out clinically significant prostate cancer with negative multi-parametric MRI.

Int Urol Nephrol 2018 Jan 15;50(1):7-12. Epub 2017 Nov 15.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-017-1715-7DOI Listing
January 2018

Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.

Radiology 2017 12 19;285(3):859-869. Epub 2017 Jul 19.

From the Molecular Imaging (M.D.G., F.V.M., P.L.C., B.T.) and Biometric Research (J.H.S.) Programs, Laboratory of Pathology (M.J.M.), and Urologic Oncology Branch (P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, Room B3B85, Bethesda, MD 20892; Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Md (N.L., R.M.S.); Department of Radiology, University of Cambridge School of Medicine, Cambridge, England (T.B.); Department of Radiology, Universidade Federal Fluminense, Rio de Janeiro, Brazil (L.K.B.); Department of Body Imaging, CDPI Clinics/DASA, Rio de Janeiro, Brazil (L.K.B.); Department of Radiology, George Washington University Hospital, Washington, DC (S.B.); Department of Radiology, Hacettepe University, Ankara, Turkey (I.M.K.); Department of Diagnostic Radiology Singapore General Hospital, Singapore (Y.M.L.); Department of Radiology, Walter Reed National Military Medical Center, Bethesda, Md (J.M.); Department of Radiology, Nephrology Center, Mansoura University, Mansoura, Egypt (H.S.); Center for Interventional Oncology, National Cancer Institute and Clinical Center, and Radiology Imaging Sciences, National Institutes of Health, Bethesda, Md (B.J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017161316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708285PMC
December 2017

Prostate Cancer: A Correlative Study of Multiparametric MR Imaging and Digital Histopathology.

Radiology 2017 10 5;285(1):147-156. Epub 2017 Jun 5.

From the Department of Computer Science and Engineering, Sejong University, Seoul, Korea (J.T.K.); Molecular Imaging Program, National Cancer Institute (S.S., B.T., P.L.C.), Center for Interventional Oncology (S.X., B.J.W.), Urologic Oncology Branch, National Cancer Institute (P.A.P.), and Laboratory of Pathology, National Cancer Institute (V.M., M.M.), National Institutes of Health, 10 Center Dr, Room 1C341, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017160906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621723PMC
October 2017

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.

Clin Nucl Med 2017 Oct;42(10):735-740

From the *Molecular Imaging Program, National Cancer Institute, Bethesda; †Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, Frederick, MD; ‡Institute of Diagnostic Radiology, Department of Medical Area, University of Udine, Udine, Italy; §Office of the Clinical Director/Center for Cancer Research/National Cancer Institute, Bethesda; ∥Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick; ¶Office of the Pharmaceutical Quality, FDA/CDER, Silver Spring; **Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore; ††Laboratory of Pathology, National Cancer Institute, Bethesda; ‡‡Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville; §§Center for Interventional Oncology, National Cancer Institute and Clinical Center, and Radiology Imaging Sciences, National Institutes of Health, Bethesda; and ∥∥Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703072PMC
October 2017

Automatic magnetic resonance prostate segmentation by deep learning with holistically nested networks.

J Med Imaging (Bellingham) 2017 Oct 21;4(4):041302. Epub 2017 Aug 21.

Imaging Biomarkers and CAD Laboratory, Clinical Center, NIH, Bethesda, Maryland, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1117/1.JMI.4.4.041302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565676PMC
October 2017

Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System.

J Urol 2017 09 31;198(3):583-590. Epub 2017 Mar 31.

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.03.131DOI Listing
September 2017

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer.

Balkan Med J 2017 09;34(5):388-396

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4274/balkanmedj.2017.0708DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635625PMC
September 2017

MRI-targeted biopsy: is systematic biopsy obsolete?

Can J Urol 2017 Aug;24(4):8876-8882

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
August 2017

Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer.

PLoS One 2016 14;11(6):e0157130. Epub 2016 Jun 14.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157130PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907470PMC
July 2017

Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy?

Urology 2017 Jul 15;105:113-117. Epub 2016 Nov 15.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.11.012DOI Listing
July 2017

Transfer learning from RF to B-mode temporal enhanced ultrasound features for prostate cancer detection.

Int J Comput Assist Radiol Surg 2017 Jul 27;12(7):1111-1121. Epub 2017 Mar 27.

The University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11548-017-1573-xDOI Listing
July 2017

Encountering "Dropped" Gallstones During Robotic-assisted Laparoscopic Radical Prostatectomy.

Urology 2017 May 16;103:e11-e12. Epub 2017 Feb 16.

Urologic Oncology Branch, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2017.02.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404999PMC
May 2017

Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations.

Int J Radiat Oncol Biol Phys 2017 04 18;97(5):947-951. Epub 2016 Dec 18.

Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.12.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364814PMC
April 2017

Detection of prostate cancer in multiparametric MRI using random forest with instance weighting.

J Med Imaging (Bellingham) 2017 Apr 12;4(2):024506. Epub 2017 Jun 12.

National Institutes of Health, Clinical Center, Imaging Biomarkers and Computer Aided Diagnosis Laboratory, Bethesda, Maryland, United States.

View Article

Download full-text PDF

Source
http://medicalimaging.spiedigitallibrary.org/article.aspx?do
Publisher Site
http://dx.doi.org/10.1117/1.JMI.4.2.024506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467765PMC
April 2017

Magnetic Resonance Imaging-Transrectal Ultrasound Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer.

J Urol 2017 03 6;197(3 Pt 1):640-646. Epub 2016 Sep 6.

Department of Urology, University of Rochester (TPF), Rochester, New York; Department of Urology, University of Michigan (AKG), Ann Arbor, Michigan; Urologic Oncology Branch (TPF, AKG, AK, MMa, MK, AM, HH, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Surgical Pathology (MMe), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Molecular Imaging Program (PLC, BT), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Interventional Oncology (BW, PAP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Division of Cancer Prevention (HLP), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Division of Urology, University of Maryland, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.08.109DOI Listing
March 2017

Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.

J Magn Reson Imaging 2017 02 8;45(2):579-585. Epub 2016 Jul 8.

Molecular Imaging Program, NCI, NIH, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.25372DOI Listing
February 2017

Robotic System for MRI-guided Focal Laser Ablation in the Prostate.

IEEE ASME Trans Mechatron 2017 Feb 22;22(1):107-114. Epub 2016 Sep 22.

College of Engineering, The University of Georgia, Athens, GA, 30605, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1109/TMECH.2016.2611570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506217PMC
February 2017

Does Abstinence From Ejaculation Before Prostate MRI Improve Evaluation of the Seminal Vesicles?

AJR Am J Roentgenol 2016 Dec 22;207(6):1205-1209. Epub 2016 Sep 22.

3 Molecular Imaging Program, National Institutes of Health, 10 Center Dr, Bldg 10, Rm B3B85, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.16.16278DOI Listing
December 2016

Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.

Future Oncol 2016 Nov 12;12(21):2417-2430. Epub 2016 Jul 12.

Urological Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066119PMC
November 2016

Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidney.

Int Urol Nephrol 2016 Nov 11;48(11):1817-1821. Epub 2016 Aug 11.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Building 10, Room 2 W-5940, 10 Center Drive, MSC 1210, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11255-016-1392-y
Publisher Site
http://dx.doi.org/10.1007/s11255-016-1392-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090974PMC
November 2016

Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer.

Pharm Res 2016 10 24;33(10):2459-69. Epub 2016 Jun 24.

Center for Interventional Oncology, Radiology & Imaging Sciences, Clinical Center, National Institutes of Health, MSC 1182- building 10- room 1c -341, 10 Center Drive, Bethesda, Maryland, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-016-1971-8DOI Listing
October 2016

Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.

J Urol 2016 Sep 18;196(3):690-6. Epub 2016 Apr 18.

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.04.057DOI Listing
September 2016

Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.

J Natl Cancer Inst 2016 09 29;108(9). Epub 2016 Apr 29.

Urologic Oncology Branch (MMS, AKG, RR, SRB, BJW, PAP), Molecular Imaging Program (BT, PLC), Division of Cancer Prevention (HLP), Laboratory of Pathology (MJM), and Center for Interventional Oncology, Department of Radiology and Imaging Sciences (BJW, PAP), National Cancer Institute, National Institutes of Health, Bethesda, MD; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD (RMS); Department of Surgery, Division of Urology, University of Maryland, Baltimore MD (MMS); Departments of Urology and Radiology, University of Alabama at Birmingham, Birmingham, AL (SRB)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059120PMC
September 2016

Editorial Comment.

J Urol 2016 09 2;196(3):733. Epub 2016 Jun 2.

National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.03.186DOI Listing
September 2016

Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification.

Int Urol Nephrol 2016 Sep 15;48(9):1445-52. Epub 2016 Jun 15.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Room 1-5940, 20892, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-016-1336-6DOI Listing
September 2016

Editorial Comment.

J Urol 2016 08 4;196(2):381. Epub 2016 May 4.

National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.02.2991DOI Listing
August 2016

Corrigendum to "A Case of In-Bore Transperineal MRI-Guided Prostate Biopsy of a Patient with Ileal Pouch-Anal Anastomosis".

Case Rep Urol 2016 27;2016:3012941. Epub 2016 Jul 27.

Urologic Oncology Branch, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA; Center for Interventional Oncology, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/3012941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978827PMC
August 2016

Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Top Magn Reson Imaging 2016 Jun;25(3):139-47

*Molecular Imaging Program, NCI, NIH, Bethesda, MD †Department of Radiology, George Washington University Hospital, Washington, DC ‡Hacettepe University, School of Medicine, Department of Radiology, Ankara, Turkey §Laboratory of Pathology, NCI ¶Center for Interventional Oncology, NCI and Radiology and Imaging Sciences, Clinical Center ||Urologic Oncology Branch, NCI, NIH, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RMR.0000000000000088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462597PMC
June 2016

Editorial Comment.

J Urol 2016 May 23;195(5):1427. Epub 2016 Feb 23.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.11.094DOI Listing
May 2016

A urologist's perspective on prostate cancer imaging: past, present, and future.

Abdom Radiol (NY) 2016 05;41(5):805-16

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 1-5940, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-016-0751-6DOI Listing
May 2016

DCE MRI of prostate cancer.

Abdom Radiol (NY) 2016 05;41(5):844-53

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182 Bldg 10, Room B3B85, Bethesda, MD, 20892-1088, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-015-0589-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462146PMC
May 2016

Magnetic Resonance Imaging-Ultrasound Fusion-Guided Prostate Biopsy: Review of Technology, Techniques, and Outcomes.

Curr Urol Rep 2016 Apr;17(4):32

Urologic Oncology Branch, National Institutes of Health, National Cancer Institute, 10 Center Drive, Bethesda, MD, 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-016-0589-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928379PMC
April 2016